| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Email: |
sales@invivochem.cn |
| Products Intro: |
Product Name:KN 1022
CAS:205255-11-4
Purity:98% HPLC Package:1mg Remarks:V16229
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:KN1022
CAS:205255-11-4
Purity:99.00% Package:1mg;2mg;5mg
|
1-Piperazinecarboxamide, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)- manufacturers
- KN1022
-
- $70.00 / 1mg
-
2026-01-26
- CAS:205255-11-4
- Min. Order:
- Purity: 99.88%
- Supply Ability: 10g
|
| | 1-Piperazinecarboxamide, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)- Basic information |
| | 1-Piperazinecarboxamide, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)- Chemical Properties |
| Melting point | 272-274 °C(Solv: chloroform (67-66-3); methanol (67-56-1)) | | Boiling point | 711.1±60.0 °C(Predicted) | | density | 1.406±0.06 g/cm3(Predicted) | | pka | 12.73±0.70(Predicted) |
| | 1-Piperazinecarboxamide, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)- Usage And Synthesis |
| Uses | KN1022 an inhibitor of phosphorylation of platelet-derived growth factor receptor (PDGFR) with IC50 of 0.24 μM[1]. | | References | [1] Kenji Matsuno, et al. Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 1. Synthesis, structure-activity relationship, and biological effects of a new class of quinazoline derivatives. J Med Chem. 2002 Jul 4;45(14):3057-66. DOI:10.1021/jm010428o |
| | 1-Piperazinecarboxamide, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-nitrophenyl)- Preparation Products And Raw materials |
|